Encourage Your Patients to Participate! US-Based Clinical Trials That Are Actively Recruiting in Breast Cancer.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 17
- Publication type:
- Article
Works matching IS 21644403 AND DT 2024 AND VI 14 AND IP 12
Results: 9
1
2
FDA OKs Zolbetuximab-clzb With Chemo for Gastric, Gastroesophageal Junction Adenocarcinoma.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 16
- Publication type:
- Article
3
FDA Grants Accelerated Approval to Asciminib for Adults With Certain Type of Newly Diagnosed Chronic Myeloid Leukemia.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 15
- Publication type:
- Article
4
FDA Greenlights Obecabtagene Autoleucel for Relapsed, Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 15
- Publication type:
- Article
5
FDA OKs Revumenib for Relapsed, Refractory Acute Leukemia With KMT2A Translocation.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 15
- Publication type:
- Article
6
2024 American Society of Clinical Oncology Quality Care Symposium.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 13
- Publication type:
- Article
7
Biosimilars in Oncology Can Reduce Healthcare Costs.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 11
- By:
- Publication type:
- Article
8
When a Nurse Doubles as a Practice Manager: Thoughts on Running a Successful Community Practice.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 9
- By:
- Publication type:
- Article
9
2024--Defending Patients and Their Access to Safe, Timely Care.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 12, p. 6
- By:
- Publication type:
- Article